The board of directors of Yestar International Holdings Company Limited announced that, based on a preliminary review and assessment of the unaudited management accounts of the Group for the year ended December 31, 2014, the group is expected to record an increase of not less than 40% in its consolidated net profit for the year ended December 31, 2014 as compared with that of the year ended December 31, 2013 (audited consolidated net profit of the Group for the year ended December 31, 2013 amounted to approximately RMB 65,335,000). The substantial increase is mainly attributable to the significant growth of net profit from the provision of medical products of the Group's medical business.